Integrating AI Agents with NextGen Healthcare
Last updated / Reviewed by Clunic Research Team
Quick answer
AI agents reach NextGen through three published developer tracks: free Patient Access APIs, an Open Access track for a practice building for itself, and a commercial API Distributor Program with a sandbox. NextGen Connect handles HL7 and legacy interfaces. The wrinkle is that NextGen's own Ambient Assist is powered by a vendor you could also buy directly.
Free tool
Twelve factual questions on data access, governance and change capacity.
Need it signed off?
Thirty free minutes with an analyst on the vendor, the workflow and the rule you are unsure about.
Book an evaluation callIntegration methods
The routes data can travel on this platform. Which one a vendor uses decides how much of the work lands on your team.
NextGen API Developer Program
NextGen publishes three distinct access tracks, and knowing which one applies to you is the whole game. Patient Access APIs cover the patient facing data required under the certification rules and are free to develop against. The Open Access Developer Program covers a client building an integration for its own internal use, with no fee stated. The API Distributor Program is the commercial track for a vendor distributing a product, and it is the one that includes a sandbox.
NextGen states there is no charge to develop, and that fees may apply based on the scope of data needed and other requirements. That is a sentence worth pinning down in writing before you plan a budget around it.
FHIR R4 and SMART App Launch
NextGen documents FHIR R4, with legacy DSTU2 still supported on the patient access side, and describes NextGen Office FHIR APIs as compliant with the 21st Century Cures Act requirements including SMART App Launch and Bulk FHIR export.
SMART App Launch is the path to an agent that opens in context inside the chart rather than in a second window, and it is the difference between a tool clinicians use and one they mean to use. Bulk export matters for a different reason: it is your answer to how you get your data out if you change either vendor or platform.
NextGen Connect
The interoperability engine formerly known as Mirth Connect, covering HL7 v2, FHIR R4, C-CDA and Direct messaging, with its own partner programme. For multi site groups this is often where the real integration lives, because it is where the existing lab, imaging and referral interfaces already run.
If your organisation already has Connect expertise, that is a genuine asset and it changes which vendors are viable for you. If it does not, do not let a vendor's architecture quietly assume it does.
NextGen API Marketplace
NextGen runs a marketplace listing third party applications by category across clinical care, patient engagement and practice management. As with every marketplace on this site, a listing tells you a vendor has done integration work. It does not tell you they are live at a practice like yours, and vendors routinely blur the two in a sales call.
NextGen Mobile
NextGen's mobile client, and the delivery surface for its own ambient documentation product. For ambient capture the mobile client matters more than any server side path, because the microphone recording the encounter is usually the phone already in the clinician's pocket. Ask any third party scribe vendor how their capture step works when the clinician is not at a desk.
Why is the NextGen integration question different?
Because of who buys NextGen. The platform is aimed at specialty and multi site ambulatory groups rather than at hospitals or at solo clinicians, and those organisations sit in an awkward middle: big enough to have real workflow complexity, often too small to have a dedicated integration team.
That produces a specific failure pattern. A group of forty clinicians across six sites and three specialties buys an agent on the strength of a demo, then discovers that the specialty templates, the referral workflow and the interfaces at two of the sites all behave differently. The technology worked. The rollout did not.
The second difference is that NextGen publishes its developer tiers openly, which is unusually helpful. You can find out which track a vendor is on before you take the call, and that tells you more than the demo does. Compare that with Epic, where the constraint is your own queue, or eClinicalWorks, where it is that nobody owns integration at all.
What are the actual integration paths into NextGen?
Four that matter, and the developer track determines the terms.
| Track or path | Who it is for | Sandbox | Fees |
|---|---|---|---|
| Patient Access APIs | Patient facing apps under the certification rules | Not stated | Free to develop |
| Open Access Developer Program | A NextGen client building for its own use | Not stated | No fee stated |
| API Distributor Program | A vendor distributing a commercial product | Yes | May apply, based on scope of data |
| NextGen Connect | HL7, C-CDA and Direct interfaces | Your own environment | Depends on your licensing |
Ask a prospective vendor which track they are on and when they were onboarded. A vendor on the Distributor track has passed a commercial process and has a sandbox. A vendor describing an integration it built once for one client under Open Access has something else, and it may still be fine, but it is not a product. We ask this the same way on every platform, which is why the EHR integration pages share a shape.
What is NextGen Ambient Assist, and does it compete with your shortlist?
Yes, and the detail underneath is the useful part.
NextGen Ambient Assist is NextGen's own ambient documentation product, announced in 2023, delivered through NextGen Mobile and writing into NextGen Enterprise. A version tailored to smaller practices followed for NextGen Office. The AI underneath it is Nabla's, under a partnership both companies announced publicly.
So the honest framing is not first party versus third party. It is the same underlying documentation engine, sold to you two ways: bundled and supported by your EHR vendor, or bought direct with a different contract and a different integration path. Which is better depends on things that have nothing to do with note quality. Ask what happens at renewal, who you call when a note is wrong, and whether the bundled version lags the direct product on features.
On the numbers, be careful. NextGen's own product page carries a claim of up to two hours saved daily and, elsewhere on the same page, up to two and a half hours. Press coverage has cited one and a half to two hours. These are vendor supplied figures and they are not consistent with each other. Measure it yourself against your own baseline; the ROI calculator shows its assumptions on the page so you can substitute your own.
What does being multi specialty do to a rollout?
It multiplies the work in a way that pilots hide. NextGen positions itself across a broad set of specialties, and specialty depth is a real differentiator between ambient vendors: a note that reads well in family medicine can be useless in orthopaedics or ophthalmology.
Two practical rules. First, pilot in your hardest specialty rather than your easiest, because the easy one will succeed regardless and tells you nothing. Second, budget separate configuration time per specialty rather than assuming a single template rollout, and get the vendor to say in writing how many of your specialties they have live customers in.
Multi site adds a second axis. Sites that joined the group through acquisition often run different builds and different interfaces, and the agent will meet all of them. If you want that mapped before you commit, that is what an AI readiness audit produces.
What does your organisation have to do?
More than the demo suggests, and the steps groups skip are always the same.
- Name an integration owner with authority across all your sites, not one per site.
- Establish which developer track your vendor is on and what NextGen will charge, in writing, before you sign.
- Find out who holds your NextGen Connect expertise, internally or at a partner, and whether they have capacity.
- Run the business associate agreement in parallel with the technical work, not after it.
- Agree what gets written back, in which template, per specialty.
- Set a decision date and a named owner for the pilot verdict.
We turn this into a sequence in a deployment roadmap, because multi site ambulatory projects rarely fail technically. They stall.
What leverage do the certification rules give you?
Certified health IT has to publish its API documentation and its terms, which is part of why NextGen's developer tiers are public in the first place. The information blocking provisions constrain what a developer may do to obstruct access to electronic health information, and that is a real lever if an integration request stalls for a reason nobody will put in writing.
The HTI-1 rule also brought transparency requirements for predictive decision support shipped inside certified software. If AI functionality inside your EHR influences care decisions, those disclosures exist, and your governance committee should have them on file rather than discover them during an incident.
What does HIPAA add on top of the integration?
Integration and compliance are separate approvals on separate clocks, and multi site groups tend to run them in sequence when they should run in parallel.
Ask where audio and transcripts are stored, how long they are retained, whether your data trains shared models, which subprocessors touch it, and what happens to it at the end of the contract. On a bundled product, ask these questions of both parties, because the EHR vendor selling you the AI is not necessarily the party holding the audio. The HIPAA and AI compliance page sets out what to insist on.
Which agent use cases fit NextGen practices first?
Ambient documentation is the usual first project, with the bundling question above settled first rather than discovered halfway through a pilot.
Second is the front desk. Specialty groups on NextGen carry heavy inbound call volume and referral coordination, and scheduling and phone agents are high volume with low clinical risk. NextGen's marketplace has patient engagement listings, so this is a supported category rather than a bespoke build.
Third is revenue cycle. Waystar holds a preferred partner designation with NextGen and Availity has a long standing data sharing arrangement, so prior authorization and eligibility work generally have shorter paths than anything touching the clinical record.
Anything that orders, prescribes or acts without human review belongs later, and in a governance conversation rather than a procurement one.
How should a NextGen group sequence this?
Settle the bundling question in week one. Get quotes for the bundled product and for the direct product, and compare them on renewal terms and support path as well as on price.
Then pilot in your hardest specialty, at a site that is representative rather than convenient, with a named owner and a decision date. Groups that skip the decision date do not fail, they drift, and drift is more expensive than a failed pilot because nobody records it as a loss.
If you are comparing platforms as well as products, athenahealth and Veradigm answer the same first party question differently. Mapping that for your own group is what our vendor selection work is for.
Sources
- ONC Health IT Certification Program and the HTI-1 final ruleONC
- Information blockingONC
- HIPAA Security Rule, HHS Office for Civil RightsHHS
- NextGen API Developer ProgramOther
- NextGen APIs and FHIR documentationOther
- Nabla powers NextGen Healthcare's Ambient AssistOther
- Top ambulatory EHR systems by market share, Definitive HealthcareOther
Vendor compatibility
How each vendor connects, as that vendor publicly documents it. Native means the connection is built into the platform, API means it is built on the published interfaces, workaround means neither and someone has to bridge it.
| Vendor | Category | Integration depth |
|---|---|---|
| Nabla | Ambient documentation | Native |
| Waystar | Revenue cycle | Native |
| Availity | Payer connectivity | Native |
| Assort Health | Voice agents | API |
| DeepScribe | Ambient documentation | API |
Questions we get asked
Does NextGen charge for API access?
NextGen states there is no charge to develop against its APIs, and that fees may apply depending on the scope of data needed and other requirements. That leaves real room for a number to appear later. Get the position in writing for your specific use case before you sign with an agent vendor, and ask the vendor what they pay as well.
Who actually powers NextGen Ambient Assist?
NextGen and Nabla both announced publicly that Nabla's technology powers Ambient Assist. That means you can reach substantially the same documentation engine either bundled through NextGen or bought directly from Nabla, on different contracts and through different integration paths. Compare both rather than assuming the bundled route is cheaper.
Is NextGen still owned by Thoma Bravo?
Thoma Bravo completed its take private acquisition of NextGen Healthcare in November 2023 in a transaction valued at about 1.8 billion US dollars, and the company has operated privately since. A brand refresh in 2026 changed the visual identity, not the company name or structure. The practical implication for a buyer is ordinary: private ownership means less public disclosure to read before you sign.
What is the difference between NextGen Enterprise and NextGen Office?
NextGen Enterprise is the platform for larger and multi site ambulatory organisations. NextGen Office is the cloud product aimed at smaller practices. They are different products with different API surfaces and, in the case of ambient documentation, different release timing. When a vendor says they integrate with NextGen, ask which one.
Do we need NextGen Connect expertise to deploy an AI agent?
Not for an API based integration on the Distributor track. You do need it if the workflow depends on HL7 feeds, on existing interfaces, or on anything crossing between sites with different builds. Find out who holds that expertise in your organisation before a vendor's plan quietly assumes you have it.
How long does a NextGen integration take?
There is no honest single number, and the variance sits with the number of specialties and sites rather than with the API. The predictable part is the sequence: developer track and fees confirmed, business associate agreement, sandbox validation, configuration per specialty, pilot on real encounters, then a controlled rollout site by site. Confirm the middle steps before you promise clinicians a date.
Make it a formal evaluation
Everything we publish is free to read and free to argue with. When the decision has to be signed, dated and defended to a board, we run the evaluation against your own estate. We take no vendor commissions.
- A 30 minute evaluation call with an analyst, no pitch deck.
- A read on the vendors and the rules in play, and the use cases we would not touch yet.
- A written proposal with scope, sequence and a fixed fee.
- No obligation
- Direct with an analyst, not a sales rep
- BAA available before any PHI discussion